A Phase I Study of TS-142 in Healthy Participants (Single Doses)

NCT04169893 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Placebo (fasting)
DRUG: Placebo (feeding)
DRUG: 1 mg of TS-142
DRUG: 3 mg of TS-142
DRUG: 10 mg of TS-142 (fasting)
DRUG: 10 mg of TS-142 (feeding)
DRUG: 30 mg of TS-142

Sponsor

Taisho Pharmaceutical Co., Ltd.